Literature DB >> 33755912

Indole-3-carboxaldehyde regulates RSV-induced inflammatory response in RAW264.7 cells by moderate inhibition of the TLR7 signaling pathway.

Xianbang Hou1, Xueyuan Zhang2, Jingting Bi2, Anhong Zhu1, Liwei He3,4.   

Abstract

Human respiratory syncytial virus (RSV) is highly contagious and the leading cause of severe respiratory tract illness in infants, elderly, and immunocompromised individuals. Toll-like receptor 7 (TLR7), a pattern recognition receptor recognising the ssRNA of RSV, activates proinflammatory pathways and triggers secretion of interferons (IFNs). On the one hand, the inflammatory responses help clear out virus. On the other hand, they lead to severe lung damage. Banlangen is a traditional Chinese herbal medicine commonly prescribed for respiratory virus infection treatment, but the mechanisms of action and active components remain largely unknown. In the present study, we investigated the effects of the main active components of total alkaloids from banlangen (epigoitrin, indole-3-carboxaldehyde, indole-3-acetonitrile and 4-methoxyindole-3-acetonitrile) on the RSV-induced inflammatory responses in mouse macrophage cells (RAW264.7). Our results demonstrated that RSV-induced IFN-α excessive secretion was moderately inhibited by indole-3-carboxaldehyde through downregulation of mRNA expression in a dose-dependent manner, in comparison, the inhibitory effects of ribavirin were too strong. Furthermore, we revealed that indole-3-carboxaldehyde suppressed transcription of IFN-α by inhibiting RSV-induced TLR7 expression in RAW264.7 cells. Additionally, indole-3-carboxaldehyde inhibited RSV-induced NF-κB signalling activation in a TLR7-MyD88-dependent manner. Together, our findings suggest that indole-3-carboxaldehyde inhibited RSV-induced inflammatory injury by moderate regulation of TLR7 signaling pathway and did not significantly affect the viral clearance competence of the innate immune system.

Entities:  

Keywords:  Indole-3-carboxaldehyde; NF-κB; Respiratory syncytial virus; TLR7

Year:  2021        PMID: 33755912     DOI: 10.1007/s11418-021-01506-0

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  20 in total

Review 1.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 2.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

Review 3.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

Review 4.  Toll-like Receptors and the Control of Immunity.

Authors:  Katherine A Fitzgerald; Jonathan C Kagan
Journal:  Cell       Date:  2020-03-11       Impact factor: 66.850

Review 5.  Innate immune recognition of respiratory syncytial virus infection.

Authors:  Tae Hoon Kim; Heung Kyu Lee
Journal:  BMB Rep       Date:  2014-04       Impact factor: 4.778

6.  Risk of mortality associated with respiratory syncytial virus and influenza infection in adults.

Authors:  Yong Shik Kwon; Sun Hyo Park; Mi-Ae Kim; Hyun Jung Kim; Jae Seok Park; Mi Young Lee; Choong Won Lee; Sonila Dauti; Won-Il Choi
Journal:  BMC Infect Dis       Date:  2017-12-20       Impact factor: 3.090

7.  Indirubin, a bisindole alkaloid from Isatis indigotica, reduces H1N1 susceptibility in stressed mice by regulating MAVS signaling.

Authors:  Chong Jie; Zhuo Luo; Huan Chen; Min Wang; Chang Yan; Zhong-Fu Mao; Gao-Keng Xiao; Hiroshi Kurihara; Yi-Fang Li; Rong-Rong He
Journal:  Oncotarget       Date:  2017-11-09

8.  Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan.

Authors:  Najwa Khuri-Bulos; Lindsey Lawrence; Bhinnata Piya; Li Wang; Christopher Fonnesbeck; Samir Faouri; Asem Shehabi; Sten H Vermund; John V Williams; Natasha B Halasa
Journal:  BMJ Open       Date:  2018-05-20       Impact factor: 2.692

Review 9.  Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.

Authors:  Bernhard Resch
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

10.  Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection.

Authors:  Michelle Goritzka; Lydia R Durant; Catherine Pereira; Samira Salek-Ardakani; Peter J M Openshaw; Cecilia Johansson
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

View more
  3 in total

1.  Molecular Mechanism of Jinchan Oral Liquid in the Treatment of Children with Respiratory Syncytial Virus Pneumonia Based on Network Pharmacology and Molecular Docking Technology.

Authors:  Li Shen; Yiguo Jiang; Jinmiao Lu; Guangfei Wang; Xiaolan Zhang; Sumei He; Cheng Wang; Zhiping Li
Journal:  Biomed Res Int       Date:  2021-08-26       Impact factor: 3.411

Review 2.  What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.

Authors:  Raymond Vanholder; Sanjay K Nigam; Stéphane Burtey; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2022-03-17       Impact factor: 4.546

3.  A Network Pharmacology-Based Investigation to the Pharmacodynamic Material Basis and Mechanisms of the Anti-Inflammatory and Anti-Viral Effect of Isatis indigotica.

Authors:  Jiuling Deng; Ying Ma; Yuqiong He; Shi Qiu; Hong Yang; Yanhong Chen; Liang Wang; Doudou Huang; Xia Tao; Wansheng Chen
Journal:  Drug Des Devel Ther       Date:  2021-07-20       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.